EX-10.8





 Exhibit 10.8 

DA32 LIFE SCIENCE TECH ACQUISITION CORP. 

345 Park Avenue South, 12th Floor 

New York, NY 10010 
 [●], 2021

 DA32 Sponsor LLC 
 345 Park Avenue South, 12th Floor 
 New York, NY 10010 

Re: Administrative Services Agreement 

Ladies and Gentlemen: 
 This letter agreement
(this “Agreement”) by and between DA32 Life Science Tech Acquisition Corp. (the “Company”) and DA32 Sponsor LLC (the “Sponsor”), dated as of the date hereof, will confirm our
agreement that, commencing on the date the securities of the Company are first listed on The Nasdaq Capital Market (the “Listing Date”), pursuant to a Registration Statement on Form
S-1 and prospectus filed with the U.S. Securities and Exchange Commission (the “Registration Statement”) and continuing until the earlier of the consummation by the Company of an
initial business combination or the Company’s liquidation (in each case as described in the Registration Statement) (such earlier date hereinafter referred to as the “Termination Date”): 

1.    The Sponsor shall make available, or cause to be made available, to the Company, at 345 Park Avenue South, 12th Floor, New York, New York 10010 (or any successor location), office space and secretarial and administrative services as may be reasonably required by the Company. In exchange therefor, the Company
shall pay the Sponsor $10,000 per month on the Listing Date and continuing monthly thereafter until the Termination Date; and 

2.    The Sponsor hereby irrevocably waives any and all right, title, interest, causes of action and claims of any kind as
a result of, or arising out of, this Agreement (each, a “Claim”) in or to, and any and all right to seek payment of any amounts due to it out of, the trust account established for the benefit of the public stockholders of the
Company and into which substantially all of the proceeds of the Company’s initial public offering will be deposited (the “Trust Account”), and hereby irrevocably waives any Claim it may have in the future as a
result of, or arising out of, this Agreement, which Claim would reduce, encumber or otherwise adversely affect the Trust Account or any monies or other assets in the Trust Account, and further agrees not to seek recourse, reimbursement, payment or
satisfaction of any Claim against the Trust Account or any monies or other assets in the Trust Account for any reason whatsoever. 
 This
Agreement constitutes the entire agreement and understanding of the parties hereto in respect of its subject matter and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the
extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. 
 This Agreement may not be amended,
modified or waived as to any particular provision, except by a written instrument executed by the parties hereto. 
 No party hereto may
assign either this Agreement or any of its rights, interests, or obligations hereunder without the prior written approval of the other party. Any purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate
to transfer or assign any interest or title to the purported assignee. 












 This Agreement constitutes the entire relationship of the parties hereto, and any litigation
between the parties (whether grounded in contract, tort, statute, law or equity) shall be governed by, construed in accordance with, and interpreted pursuant to the laws of the State of New York. 

[Signature Page Follows] 












 
			
	 Very truly yours,
  

	DA32 LIFE SCIENCE TECH ACQUISITION CORP.
		
	By:	 	 
		 	Name: Christopher Wolfe
		 	Title: Chief Financial Officer


  

			
	 AGREED AND ACCEPTED BY:
  

	DA32 SPONSOR LLC
		
	By:	 	DEERFIELD PARTNERS, L.P., its Managing Member
		
	By:	 	Deerfield Mgmt, L.P.
		
	Its:	 	General Partner
		
	By:	 	J.E. Flynn Capital, LLC
		
	Its:	 	General Partner
		
	By:	 	 
		 	Name: David Clark
		 	Title: Authorized Signatory